ACON News

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Form 8-K

Aclarion Announces $2.5 Million Stock Repurchase Plan

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aclarion Receives Pinnacle Award for AI Innovation

Aclarion Announces Agreement with Weill Cornell Medicine

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc.

Form 8-K